(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBD introduced) (SBAR (S (NP (NP (DT a) (JJ novel) (NN feature) (NN extraction) (NN approach)) (, ,) (VP (VBN named) (NP (NP (JJ exclusive) (NN autoencoder) (PRN (-LRB- -LRB-) (NP (NN XAE)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (JJ supervised) (NN version)) (PP (IN of) (NP (NN autoencoder)))))))) (PRN (-LRB- -LRB-) (NP (NN AE)) (-RRB- -RRB-))) (, ,)) (ADJP (JJ able) (S (VP (TO to) (ADVP (RB largely)) (VP (VB improve) (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NN nucleus) (NN detection) (CC and) (NN classification)))) (PP (IN on) (NP (NML (NML (NN hematoxylin)) (CC and) (NML (NN eosin) (-LRB- -LRB-) (NN H&E) (-RRB- -RRB-))) (JJ histopathological) (NNS images)))))))))) (. .))
(S (NP (DT The) (VBN proposed) (NN XAE)) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN in) (NP (ADJP (NP (DT any) (NN AE)) (HYPH -) (VBN based)) (NN algorithm))) (, ,) (SBAR (ADVP (RB as) (RB long)) (IN as) (S (NP (DT the) (NNS data) (NNS labels)) (VP (VBP are) (ADVP (RB also)) (VP (VBN provided) (PP (IN in) (NP (DT the) (NN feature) (NN extraction) (NN phase)))))))))) (. .))
(S (PP (IN In) (NP (DT the) (NNS experiments))) (, ,) (NP (PRP we)) (VP (VBD evaluated) (NP (DT the) (NN performance)) (PP (PP (IN of) (NP (NP (DT an) (NN approach)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT the) (NN combination)) (PP (IN of) (NP (NP (DT an) (NN XAE)) (CC and) (NP (DT a) (ADJP (RB fully) (VBN connected)) (JJ neural) (NN network))))) (PRN (-LRB- -LRB-) (NP (NN FCN)) (-RRB- -RRB-))))))) (CC and) (PP (VBN compared) (PP (IN with) (NP (ADJP (NP (DT some) (NN AE)) (HYPH -) (VBN based)) (NNS methods)))))) (. .))
(S (PP (IN For) (NP (NP (NP (DT a) (NML (NN nucleus) (NN detection)) (NN problem)) (-LRB- -LRB-) (VP (VBN considered) (PP (IN as) (NP (DT a) (NML (NN nucleus) (HYPH /) (NN non-nucleus)) (NN classification) (NN problem)))) (-RRB- -RRB-)) (PP (IN on) (NP (NML (NN breast) (NN cancer)) (NN H&E) (NNS images))))) (, ,) (NP (NP (DT the) (NN F) (HYPH -) (NN score)) (PP (IN of) (NP (DT the) (VBN proposed) (NN XAE+FCN) (NN approach)))) (VP (VBD achieved) (NP (CD 96.64) (NN %)) (SBAR (IN while) (S (NP (DT the) (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art))))) (VP (VBD was) (PP (IN at) (NP (CD 84.49) (NN %))))))) (. .))
(UCP (PP (IN For) (NP (NP (NN nucleus) (NN classification)) (PP (IN on) (NP (JJ colorectal) (NML (NN cancer) (NN H&E)) (NNS images))) (, ,) (PP (IN with) (NP (DT the) (NML (NML (NNS annotations)) (PP (IN of) (NP (NP (CD four) (NNS categories)) (PP (IN of) (NP (NP (JJ epithelial)) (, ,) (NP (JJ inflammatory)) (, ,)))))) (NN fibroblast))))) (CC and) (NP (JJ miscellaneous) (NNS nuclei)) (. .))
(S (NP (NP (DT The) (NN F) (HYPH -) (NN score)) (PP (IN of) (NP (DT the) (JJ proposed) (NN method)))) (VP (VBD reached) (NP (CD 70.4) (NN %))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD proposed) (NP (DT a) (NN lymphocyte) (NN segmentation) (NN method))) (. .))
(S (PP (IN In) (NP (NP (DT the) (NN step)) (PP (IN of) (NP (NN lymphocyte) (NN detection))))) (, ,) (NP (PRP we)) (VP (VP (VBP have) (VP (VBN compared) (PP (IN with) (NP (NML (NN cutting) (HYPH -) (NN edge)) (NN technology))))) (CC and) (VP (VBD gained) (NP (VBN improved) (NN performance)) (PP (IN from) (NP (QP (CD 90) (NN %) (IN to) (CD 98.67) (NN %)))))) (. .))
(S (NP (PRP We)) (ADVP (RB also)) (VP (VBD proposed) (NP (NP (DT an) (NN algorithm)) (PP (IN for) (NP (NN lymphocyte) (NN segmentation)))) (PP (VBN based) (PP (IN on) (NP (NN nucleus) (NN detection) (CC and) (NN classification))))) (. .))
(S (NP (DT The) (ADJP (VBN obtained)) (NN Dice) (NN coefficient)) (VP (VBD achieved) (NP (CD 88.31) (NN %)) (SBAR (IN while) (S (NP (DT the) (NML (NN cutting) (HYPH -) (NN edge)) (NN approach)) (VP (VBD was) (PP (IN at) (NP (CD 74) (NN %))))))) (. .))
